Skip to main content
. 2021 May 26;13:632138. doi: 10.3389/fnagi.2021.632138

Table 1.

Comparison of the baseline demographic and clinical characteristics between patients with and without hematoma growth.

Variables Hematoma growth (n = 28) Without hematoma growth (n = 90) P-value
Demographic
  Age, year (IQR) 48.5 (38.25–62.75) 60 (53–65.25) 0.012
Sex, male, n (%) 23 (82.1) 61 (67.8) 0.143
Medical history
  Hypertension, n (%) 18 (64.3) 64 (71.1) 0.493
  Diabetes mellitus, n (%) 5 (17.9) 18 (20.0) 0.803
  Coronary heart disease, n (%) 5 (17.9) 12 (13.3) 0.552
  Alcohol consumption, n (%) 9 (32.1) 25 (27.8) 0.656
  Smoking, n (%) 12 (42.9) 25 (27.8) 0.133
Clinical features
  Admission SBP, mmHg (median) 185.0 162.5 0.006
  Admission DBP, mmHg (SD) 106.0 (21.2) 93.8 (16.2) 0.002
  Baseline GCS score, median (mean rank) 8 (46.27) 9 (63.62) 0.018
  Admission heart rate, median 96 (79.1) 78 (53.4) <0.001
Location 0.117
  Basal ganglia 17 (60.7) 33 (36.7)
Thalamus 3 (10.7) 23 (25.6)
  Lobe 5 (17.9) 25 (27.8)
Cerebellum 3 (10.7) 9 (10.0)
  Irregular hematoma 28 (100) 82 (91.1) 0.195
Intraventricular hemorrhage 9 (32.1) 50 (55.6) 0.030
  Baseline ICH volume, ml (IQR) 18.3 (14.8–20.3) 13.9 (9.0–26.0) 0.310

IQR, interquartile range; SBP, systolic blood pressure; DBP, diastolic blood pressure; SD, standard deviation; GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage.